You’ve done the hard part.

You’ve secured regulatory approval. You’ve got two pilot sites running. You’ve even got distributor interest.

But sales still aren’t landing the way you expected.

Now you’ve got 90 days. Limited runway. Board pressure building.

And you can only prioritise one move.

So what do you focus on?

1. Do you activate the distributor and push for reach?
2. Do you hire commercial support to build structure?
3. Do you refine your messaging and economic case?
4. Or do you double down somewhere else entirely?

In this episode, we break down how clinician founders should prioritise when everything feels urgent — and why most MedTech businesses stall not because the product isn’t strong, but because the commercial leverage isn’t.

You’ll discover:

1. Why regulatory approval is permission — not traction
2. The difference between interest and evidence (and why only one protects your runway)
3. The hidden risk of activating distributors too early
4. Why activity and progress are not the same thing
5. The decision framework that turns early traction into scalable momentum

If you’re a clinician building a Medical Device and trying to simplify your go-to-market strategy, this episode will challenge how you think about traction, revenue and exporting.

Because the difference between a working prototype and an international MedTech business isn’t technical strength.

It’s commercial proof.

Hit play and decide what you would prioritise — before you hear what we would do.

Message me via DM on Linkedin

Book a 30 min discovery call for the Healthcare Export Accelerator Programme

This podcast is for clinicians turning medical devices into real businesses, with practical insight on go to market strategy, exporting, and scaling in international MedTech.

Clinicians saying they love your product doesn’t mean hospitals will adopt it — and that gap is where clinician-led MedTech companies burn cash and lose momentum.

In this episode, Hakeem is joined by Mark Tudor (20+ years in commercial leadership and advisory roles in medical devices) to break down why technically strong products stall after launch, how hospitals really decide what to buy, and how to build the commercial foundations that drive adoption, sales, and export readiness.

1. Learn why commercial planning must run in parallel with product and regulatory work
2. Understand what hospitals actually buy (risk management, simplicity, and economic clarity — not “better performance”)
3. Get a practical lens for stakeholder mapping, validation beyond friendly opinions, and avoiding “inventor syndrome”

Helping clinicians simplify their go-to-market strategy so they can stop guessing and turn their working prototypes into international MedTech businesses.

Decision point scenario: You’re advising a clinician founder with regulatory approval, two pilot sites, one keen-but-unproven distributor, limited runway, and 90 days before board pressure. You can only prioritise one focus — what do you choose and why? (Mark answers in the next episode.)

If you tell me whether you want this episode to lean harder into adoption, hospital buying decisions, or export/distributor readiness, I’ll pick the best 3 titles from above and tighten them even more.

Message me via DM on Linkedin

Book a 30 min discovery call for the Healthcare Export Accelerator Programme

This podcast is for clinicians turning medical devices into real businesses, with practical insight on go to market strategy, exporting, and scaling in international MedTech.

If you only had 14 months of runway left, no international sales team, and one shot at entering a new export market… would you choose the one that looks impressive or the one that actually gives you the highest probability of revenue?

Most MedTech founders believe they’re making rational expansion decisions but under pressure, choices get driven by ego, investor optics, or the allure of a “big” market. With limited runway, one wrong move can quietly burn capital and delay global traction.

In the previous episode, you built your export business plan. Today, we pressure-test it. We walk through the exact scenario I posed and reveal which market actually wins when you apply disciplined strategy instead of ambition.

In this episode, you’ll see exactly how to eliminate two markets and confidently choose the one most likely to generate traction within 12 months.

By listening, you’ll:

1. See how to apply your export business plan to eliminate the wrong markets with confidence
2. Learn how to balance ambition with execution probability inside a 14-month runway
3. Use a 180-day reality filter to validate traction before committing capital and credibility

Press play now to learn how to choose the export market that compounds your growth not the one that drains your runway.

Message me via DM on Linkedin

Book a 30 min discovery call for the Healthcare Export Accelerator Programme

This podcast is for clinicians turning medical devices into real businesses, with practical insight on go to market strategy, exporting, and scaling in international MedTech.